• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Ethyl 1-methylpiperidine-2-carboxylate (CAS No. 30727-18-5): A Key Intermediate in Modern Pharmaceutical Synthesis

Ethyl 1-methylpiperidine-2-carboxylate, identified by the chemical formula C₉H₁₃NO₂ and assigned the CAS number 30727-18-5, is a significant intermediate in the synthesis of various pharmaceutical compounds. This compound, characterized by its piperidine core structure modified with an ester group, has garnered considerable attention in recent years due to its versatile applications in drug development.

The structural motif of Ethyl 1-methylpiperidine-2-carboxylate makes it a valuable building block for medicinal chemists. The presence of both the piperidine ring and the ester functionality allows for further chemical modifications, enabling the synthesis of a wide range of bioactive molecules. Its role as a precursor in the preparation of more complex pharmaceutical agents has been well-documented in numerous scientific studies.

In recent years, there has been a surge in research focused on developing novel treatments for neurological and infectious diseases. Ethyl 1-methylpiperidine-2-carboxylate has emerged as a crucial intermediate in several drug candidates targeting these conditions. For instance, its derivatives have been explored as potential inhibitors of enzymes involved in neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. The piperidine scaffold is particularly attractive due to its ability to mimic natural amino acid structures, thereby enhancing binding affinity to biological targets.

Moreover, Ethyl 1-methylpiperidine-2-carboxylate has found applications in the development of antiviral and antibacterial agents. Researchers have leveraged its structural features to design molecules that disrupt viral replication mechanisms or inhibit bacterial enzymes essential for survival. The ester group provides a reactive site for further functionalization, allowing chemists to tailor the properties of the final compounds to optimize their pharmacological profiles.

The synthesis of Ethyl 1-methylpiperidine-2-carboxylate typically involves multi-step organic reactions, starting from readily available precursors such as piperidine and methyl acetoacetate. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications. These improvements have been driven by the demand for high-quality intermediates in pharmaceutical manufacturing.

Recent studies have also highlighted the importance of Ethyl 1-methylpiperidine-2-carboxylate in the development of central nervous system (CNS) drugs. Its derivatives have shown promise as modulators of neurotransmitter systems, offering potential therapeutic benefits for conditions like depression, anxiety, and chronic pain. The ability to fine-tune the chemical structure of these derivatives allows for the optimization of pharmacokinetic and pharmacodynamic properties, ensuring better patient outcomes.

The growing interest in sustainable chemistry has prompted investigations into greener synthetic routes for Ethyl 1-methylpiperidine-2-carboxylate. Researchers are exploring catalytic processes that minimize waste and reduce energy consumption without compromising yield or purity. Such efforts align with global initiatives to promote environmentally responsible pharmaceutical manufacturing practices.

In conclusion, Ethyl 1-methylpiperidine-2-carboxylate (CAS No. 30727-18-5) is a versatile and indispensable intermediate in modern pharmaceutical synthesis. Its unique structural features make it a valuable tool for medicinal chemists seeking to develop innovative therapeutics. As research continues to uncover new applications for this compound, its importance in drug discovery is likely to grow even further, contributing to advancements in treating some of the most pressing health challenges faced today.

• 382-82-1(Piperidinium,2-[[2-(diethylmethylammonio)ethoxy]carbonyl]-1,1,6-trimethyl-, iodide (1:2))
• 15521-09-2(Piperidinium,1,1,2-trimethyl-6-[[2-(trimethylammonio)propoxy]carbonyl]-, iodide (1:2))
• 88013-94-9(2-Piperidinecarboxylic acid, 1-methyl-, ethyl ester, (S)-)
• 85866-14-4(2-Piperidinecarboxylicacid, 1-butyl-, ethyl ester)
• 88013-95-0(2-Piperidinecarboxylic acid, 1-methyl-, ethyl ester, (R)-)
• 155595-84-9(Pyrido[2,1-c][1,4]oxazin-1(6H)-one,hexahydro-)
• 86200-58-0(2-Piperidinecarboxylic acid, 1-butyl-, butyl ester)
• 217822-53-2(hexahydro-3H-Pyrido[2,1-c][1,4]oxazepin-1(7H)-one)
• 3425-97-6(Piperidinium,1,1,2-trimethyl-6-[[2-(trimethylammonio)ethoxy]carbonyl]-, iodide (1:2))
• 149442-04-6(3-Piperidinecarboxylicacid, 1-butyl-, ethyl ester)